Riding the Tailwind, Setting Sail for New Horizons: 2023 World Digital Therapeutics Congress Officially Launched!
As technology iterates and upgrades, “digitalization” has become ubiquitous, integrating into everyday life scenarios while reshaping the future of the healthcare industry. Driven by multiple variables—including policy reforms, technological advancements, and the impact of the pandemic—digital health is gradually transitioning from concept to reality, entering our daily lives with efficiency and convenience.
Meanwhile, engaging patients in their own health management and enabling physicians to more accurately assess the status of those under their care represent a significant trend in the development of modern medicine. Mobile technologies, telecommunication, smart devices, wearable devices, health information analytics, and personalized medicine can help patients stay informed about their health status in a timely manner, while also allowing physicians to accurately understand patients’ conditions and implement precise interventions. This emerging phenomenon within the field of healthcare informatization is known as “Digital Therapeutics.”
Since the 2010s, digital therapeutics have begun to take shape and gradually develop in the United States. With the U.S. Food and Drug Administration’s 2017 approval of Pear Therapeutics’ ReSET for substance use disorder and alcohol use disorder via the “De Novo” classification pathway for innovative medical devices, more countries and regions have turned their attention to digital therapeutics, driving tangible progress in this field. In addition to the United States, Europe—represented by the United Kingdom and Germany—and East Asia—represented by China, Japan, and South Korea—have also been actively exploring digital therapeutics.
With the rapid development of the digital health market, the global market size of Digital Therapeutics (DTx) continues to rise. In China, digital therapeutics is still in its early stages of development. The product pipelines currently undergoing clinical trials cover a wide variety of disease areas, including amblyopia, autism, Alzheimer's disease, sleep disorders, and depression and anxiety. The potential market space for digital therapeutics in China is expected to exceed RMB 10 billion within the next five years. The domestic digital therapeutics market will achieve rapid growth by first taking off in the pediatric and mental health segments.
With the advent of the digital era, digital therapeutics (DTx) will undoubtedly become a key focus area for Digital China and a strategic pillar in the construction of Healthy China. Consequently, the digital medicine model is garnering increasing attention and recognition. However, the development of digital therapeutics in China is still in its nascent stages, currently undergoing the transition from real-world clinical practice to digital therapeutic interventions. Thus, the journey toward establishing a robust digital therapeutics ecosystem remains long and arduous.
Currently, Hainan Province holds significant influence in the exploration of digital therapeutics (DTx) innovation. As China’s largest special economic zone, Hainan is advancing the development of its Free Trade Port. The central government has entrusted Hainan with the mission of promoting integrated institutional innovation, which precisely creates favorable conditions for the growth of digital therapeutics. Spanning multiple domains—including medicine, digital technology, software development, and hardware manufacturing—digital therapeutics also involves a wide range of policies covering research, regulatory approval, promotion, and reimbursement. In this regard, Hainan Province can leverage its advantages in integrated institutional innovation to foster a supportive policy environment for the development of the digital therapeutics industry.
At the conference celebrating the 30th anniversary of the establishment of Hainan Province and its special economic zone, General Secretary Xi Jinping pointed out that "Hainan should deepen supply-side structural reform, leverage its advantages, gather innovation elements, and actively develop the new generation of information technology industry and digital economy." In response to this directive, Hainan Province has seized the historical opportunity to actively promote the cluster development of the digital therapeutics industry in Hainan.
On January 25, 2022, the Health Commission of Hainan Province issued the “14th Five-Year Plan for Digital Health in Hainan Province,” explicitly listing “exploring pilot trials of digital therapeutics” as one of its 24 key tasks. This marked the first inclusion of digital therapeutics in a provincial-level plan, drawing widespread industry attention and creating a “banner” effect. On October 11 of the same year, Hainan Province further released the “Several Measures to Accelerate the Development of the Digital Therapeutics Industry in Hainan Province,” representing the first comprehensive, systematic, and actionable full-lifecycle policy support for the digital therapeutics industry both in China and globally.
Hainan has established clear objectives and action plans for the development of digital therapeutics: during the 14th Five-Year Plan period, it aims to transform Hainan into a global innovation island for digital therapeutics within two to three years, solidifying its position as a global innovation hub. By building a national demonstration zone for digital therapeutic innovation, Hainan seeks to attract global innovative resources, create a cluster of innovation resources and an industrial highland, foster the formation of digital therapeutic industry clusters, and serve as a powerful new engine for the advancement of global health initiatives and the health industry.
From August 24 to 26, 2023, the highly anticipated inaugural World Digital Therapeutics Conference will be held at the Hilton Haikou Meilan Hotel in Haikou City, Hainan Province. This conference is organized byHosted by Beijing Danhuang Technology Co., Ltd. (VB100, VCBeat, Eggshell Research Institute) and the China Primary Health Care Foundation, organized by Hainan Danhuang Technology Co., Ltd., and co-organized by the Youth Health Economics Committee of the Chinese Society of Health Economics,Supported by the Digital Therapeutics Committee of the China Medical Device Industry Association, the UK Department for Business and Trade, and Austrade,AstraZeneca Investment (China) Co., Ltd. and Hainan Eco-Software Park Strategic Cooperation，Themed “Pioneering a New Future for the Industry Ecosystem and Jointly Building a Community of Common Health for All,” the conference adopts a global perspective to foster dialogue on industrial innovation. Featuring a top-tier lineup of distinguished guests characterized by “high caliber, high level, high impact, novelty, and international reach,” it creates an premier international event that integrates cutting-edge developments in global digital therapeutics, policy interpretation, academic exchange, industry collaboration, and innovation showcases. The conference invites numerous prominent figures and high-level industry leaders from domestic and foreign government agencies, academicians and scientists, clinical experts, and corporate executives to jointly discuss, build, and share the development directions, frontier trends, and cooperative opportunities in digital therapeutics.
(Conference Structure)
Precision Focus: A Comprehensive, Multi-Dimensional “3+3+N” Ecosystem Conference
The World Digital Therapeutics Conference spans three days, deconstructing the innovation trajectory of digital therapeutics by focusing on global trends, industry pain points, and ecosystem dynamics to delve into the core of the digital therapeutics industry. The conference features a “3+3+N” structure: the first “3” comprises one World Digital Therapeutics Conference, one awards ceremony recognizing the best innovative companies and practices in digital therapeutics, and one interactive exhibition of digital health products; the second “3” includes the Hainan Initiative on Digital Therapeutics, the release of a report on the digital therapeutics field, and a launch ceremony for innovative application scenarios and solutions for digital therapeutics in Hainan; “N” refers to numerous offline activities, including specialized sub-forums, expert seminars, closed-door meetings, and premieres of innovative achievements, collectively presenting a comprehensive, multi-dimensional global thematic event.
Future Force: 2023 World Digital Therapeutics Best Innovation and Practice Enterprise Selection
2023 World Digital Therapeutics Best Innovation and Practice Enterprise AwardsGrounded in the innovation and practice ecosystem of digital therapeutics, this global selection process targets digital therapeutics enterprises worldwide. It focuses on evaluating the innovations, distinctive advantages, achievements, and the driving force and impact of participating enterprises and their submitted case studies on the global advancement of digital therapeutics during the review year. Upon announcement of the awards, significant emphasis will be placed on showcasing the innovative accomplishments and results of selected enterprises in specific application areas of digital therapeutics, thereby providing a precise platform for display and exchange. This selection serves as a concurrent event of the 2023 World Digital Therapeutics Conference, creating an ecological synergy with the conference to enhance its momentum and influence.
(QR Code for Ranking Registration)
Realistic Presentation: Digital Health Product Interactive Experience Exhibition
International Digital Therapeutics Product Innovation Exhibition Zone: Leveraging the World Digital Therapeutics Conference as a platform, this zone offers experiential displays of digital health products to global industrial parks, digital therapeutics innovators, and ecosystem partners. Anchored by the offline exhibition, it provides exhibitors and professional attendees with a targeted platform for international cooperation, commercial transactions, academic discussions, and information exchange.
Hainan Digital Therapeutics Product Achievements Exhibition Zone: As the first province in China to incorporate digital therapeutics into its provincial-level planning, Hainan boasts cutting-edge national approval policies for digital therapeutics. This zone will centrally showcase Hainan’s latest digital therapeutics policies and the digital therapeutics industrial cluster that has been built from the ground up in the region.
Multidimensional Insights: "2023 Global Digital Therapeutics Industry Report"
Initiated and authored by VCBeat, with support from authoritative experts at the Hainan Provincial Health Commission, domestic and international digital therapeutics associations, enterprises, and other institutions, the "2023 Global Digital Therapeutics Industry Report" has been released. This report provides a comprehensive analysis of frontier developments in the field of digital therapeutics from multiple perspectives, including industry, technology, talent, scientific research, and platform systems. By examining representative global cases such as the digital therapeutics industry in Hainan Province, it offers valuable insights and references for governments, research institutes, entrepreneurs, and other stakeholders.
Surging Momentum: The Hainan Initiative on Digital Therapeutics
The convening of the 2023 World Digital Therapeutics Conference marks a new starting point for the development of the digital therapeutics industry. With Hainan—a global innovation hub, cluster of innovative resources, and industrial highland for digital therapeutics—as its epicenter, the conference brought together academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, executives from multinational pharmaceutical and medical device companies as well as leading domestic healthcare enterprises, CEOs of listed companies, and renowned experts and scholars. Together, they issued the “Hainan Initiative on Digital Therapeutics” to amplify the industry’s voice, promote the empowerment of digital therapeutics within the global healthcare sector, foster the collaborative construction of a new healthcare system, facilitate the exchange of value systems, achieve bidirectional synergy and integration between technology and health, attain win-win outcomes, and advance the vision of a Shared Future for Global Health.
Conference Time:August 24–26, 2023
Conference Venue:China · Hainan Province · Haikou City · Hilton Haikou Meilan
Organizer:Beijing Danhuang Technology Co., Ltd. (VB100, VCBeat, Eggshell Research Institute), China Primary Health Care Foundation
Organizer:Hainan Danhuang Technology Co., Ltd.
Co-organizers:Youth Health Economics Committee of the Chinese Society of Health Economics
Supporting Organizations:China Medical Device Industry Association, Digital Therapeutics Committee; UK Department for Business and Trade; Austrade
Strategic Cooperation:AstraZeneca Investment (China) Co., Ltd., Hainan Eco-Software Park
Conference Scale:1,500 people
Early bird tickets for the 2023 World Digital Therapeutics Conference are now on sale for a limited time,Prices as low as ¥99!
Ticket Benefits:
1. Includes a two-day forum pass for August 25–26, excluding invitation-only meetings such as closed-door sessions;
2. Includes a simple conference lunch for the two days of August 25–26;
Conference Buffet Ticket: Original Price699Yuan,Early Bird Ticket: ¥199
Ticket Benefits:
1. Includes a two-day general admission pass for the forums on August 25–26, excluding invitation-only events such as closed-door meetings;
2. Includes buffet lunches for the two-day conference on August 25–26;
(Scan the QR code to register and snap up early-bird tickets)
Share this article to your WeChat Moments,Cannot set group visibility,Caption: With favorable winds and calm seas, it’s time to break new ground. Join us at the 2023 World Digital Therapeutics Conference! Collect 38 likes., you can get it for 399 yuan (including simple lunches for the two days of the conference)2023 World Digital Therapeutics ConferenceOne Ticket!
Choose one of the two activities to claim; scan the QR code after collecting the required likes.Add the WeChat account of the Benefits Assistant,RemarksClaim Your Conference Ticket!
(Please note: Your company and name)
